Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...
Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...
Description: Switch and Click is a YouTube channel all about mechanical keyboards. We enjoy reviewing keyboards and posting ...
CT Insider on MSN
3 points with Scott Ericson: Stats and trends in the girls basketball season (Jan. 7)
The Terriers defeated defending Class S champion Coventry 62-56 to stay unbeaten and atop the D-II standings. This article originally published at 3 points with Scott Ericson: Stats and trends in the ...
The stock of Nupur Recyclers is down almost 47% from its 52-week highs. On the financial front, the company saw revenues of ...
Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...
For several weeks, Minnesota's largest metropolitan area has been living under the strain of Operation Metro Surge, which saw ...
Understanding the basics of how a clutch system works is valuable for any snowmobiling enthusiast. It can help you diagnose ...
Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in ...
MiBolsilloColombia on MSN
Who is eligible for Amazon's $51 cashback offer?
Amazon’s FTC settlement enters a new phase, but only certain Prime users qualify to claim up to $51—and the eligibility rules ...
With the release of League of Legends patch 26.1, players will now have to keep track of plenty of champion adjustments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results